Biocon gets CRL from USFDA for anti-cancer drug
Biotechnology firm Biocon today said the US health regulator has issued complete response letter (CRL) for proposed biosimilar Pegfilgrastim, indicated for use in the treatment…
Biocon
Hot Topics
- April 6, 2018 | Kolkata Man preserves mother’s body for three years
- April 6, 2018 | Finally after 20 years Salman Khan found guilty in Blackbuck case
- March 22, 2018 | Mayawati seeks support of 10 ‘dedicated’ SP MLAs
- March 22, 2018 | Facebook chief Mark Zuckerberg vowed Wednesday to “step up” to fix problems surrounding data privacy
- March 22, 2018 | PM Modi Highlights Importance Of “Jal Shakti” On World Water Day 2018